A first: Drug lowers heart risks by curbing inflammation

For the first time, a drug has helped prevent heart attacks by curbing inflammation, a new and very different approach than lowering cholesterol, the focus for many years.People on the drug also had surprisingly lower cancer death rates, especially from lung cancer. An anti-tumor effect is an exciting possibility, but it needs much more study because the heart experiment wasn't intended to test that.Doctors say the results on the drug, canakinumab (can-uh-KIN-yoo-mab), open a new frontier. Many